You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
Interpace Diagnostics to raise $1.7M in offering
Street Talk Episode 41 - How to Win the Funding Battle, Use Fintech to Play Offense
Forward Spark Spreads Suggest Rising Profitability Of US Renewables As Sector Matures
MA Activity The Big Story In Mature Online Video Platform Market
Martina Cheung Backs The Quality Program
Interpace Diagnostics Group Inc. is issuing 2 million shares and 1.6 million pre-funded warrants to an undisclosed buyer to raise $1.7 million in net proceeds.
The shares are priced at 53 cents apiece while the warrants are exercisable at 52 cents per share.
Maxim Group LLC is the exclusive placement agent for the registered direct offering which is expected to close Dec. 22.
Funds raised will help Interpace meet working capital requirements.